These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 37321172)

  • 1. The role of trained immunity in COVID-19: Lessons for the next pandemic.
    Netea MG; Ziogas A; Benn CS; Giamarellos-Bourboulis EJ; Joosten LAB; Arditi M; Chumakov K; van Crevel R; Gallo R; Aaby P; van der Meer JWM
    Cell Host Microbe; 2023 Jun; 31(6):890-901. PubMed ID: 37321172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
    Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
    Front Immunol; 2020; 11():970. PubMed ID: 32574258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].
    Kalyuzhin OV; Andronova TM; Karaulov AV
    Ter Arkh; 2020 Dec; 92(12):195-200. PubMed ID: 33720594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic].
    Kalyuzhin OV; Andronova TM; Karaulov AV
    Ter Arkh; 2021 Jan; 93(1):108-113. PubMed ID: 33720635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
    Gupta PK
    Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality.
    Hajjo R; Tropsha A
    Pharm Res; 2020 Oct; 37(11):212. PubMed ID: 33025261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19.
    Zapolnik P; Kmiecik W; Mazur A; Czajka H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond adaptive immunity: induction of trained immunity by COVID-19 adenoviral vaccines.
    Netea MG; Joosten LA
    J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36647822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
    Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
    Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
    [No Abstract]   [Full Text] [Related]  

  • 11. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
    Basak P; Sachdeva N; Dayal D
    Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2.
    Pichler R; Diem G; Hackl H; Koutník J; Mertens LS; D Andrea D; Pradere B; Soria F; Mari A; Laukhtina E; Krajewski W; Teoh JY; Del Guidice F; Moschini M; Thurnher M; Posch W
    Front Immunol; 2023; 14():1202157. PubMed ID: 37520557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
    Alsulaiman JW; Khasawneh AI; Kheirallah KA
    J Infect Dev Ctries; 2020 Sep; 14(9):957-962. PubMed ID: 33031080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2.
    Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD
    Front Immunol; 2021; 12():812176. PubMed ID: 35095907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity.
    Lee MH; Kim BJ
    J Microbiol; 2022 Mar; 60(3):321-334. PubMed ID: 35157221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
    Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
    J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.
    Aspatwar A; Gong W; Wang S; Wu X; Parkkila S
    Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.
    Gong W; Mao Y; Li Y; Qi Y
    Int Immunopharmacol; 2022 Jul; 108():108870. PubMed ID: 35597119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.